Clinical usefulness of Glycated Albumin in the diagnosis of diabetes: Results from an Italian study.
暂无分享,去创建一个
M. Plebani | C. Cosma | M. Zaninotto | M. Ciaccio | B. Lo Sasso | M. Marinova | C. Bellia | G. Bivona | L. Agnello
[1] M. Plebani,et al. Definition of the upper reference limit of glycated albumin in blood donors from Italy , 2017, Clinical chemistry and laboratory medicine.
[2] J. Pankow,et al. Comparative Prognostic Performance of Definitions of Prediabetes in the Atherosclerosis Risk in Communities (ARIC) Study , 2016, The lancet. Diabetes & endocrinology.
[3] M. de Toro,et al. Evaluation of Bio-Rad D-100 HbA1c analyzer against Tosoh G8 and Menarini HA-8180V , 2016, Practical laboratory medicine.
[4] Shyang-Rong Shih,et al. Serum Glycated Albumin to Guide the Diagnosis of Diabetes Mellitus , 2016, PloS one.
[5] I. Takei,et al. Committee on Diabetes Mellitus Indices of the Japan Society of Clinical Chemistry-recommended reference measurement procedure and reference materials for glycated albumin determination , 2016, Annals of clinical biochemistry.
[6] M. Tulloch-Reid,et al. Glycated Albumin Identifies Prediabetes Not Detected by Hemoglobin A1c: The Africans in America Study. , 2016, Clinical chemistry.
[7] E. Schaefer,et al. A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan. , 2015, Atherosclerosis.
[8] J. Pankow,et al. Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death , 2015, Circulation.
[9] J. Hayashi,et al. Glycated albumin as a diagnostic tool for diabetes in a general Japanese population. , 2015, Metabolism: clinical and experimental.
[10] G. Lippi,et al. Advantages and Pitfalls of Fructosamine and Glycated Albumin in the Diagnosis and Treatment of Diabetes , 2015, Journal of diabetes science and technology.
[11] J. Woo,et al. Optimal glycated albumin cutoff value to diagnose diabetes in Korean adults: a retrospective study based on the oral glucose tolerance test. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[12] E. Selvin,et al. Beyond HbA1c and Glucose: the Role of Nontraditional Glycemic Markers in Diabetes Diagnosis, Prognosis, and Management , 2014, Current Diabetes Reports.
[13] Elizabeth Selvin,et al. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. , 2014, The lancet. Diabetes & endocrinology.
[14] Hiroyuki Sano,et al. Erratum to: Glycated albumin as a useful clinical biomarker for glycemic variability in type 1 diabetes assessed by continuous glucose monitoring , 2013, Diabetology International.
[15] M. Shichiri,et al. New Indices for Predicting Glycaemic Variability , 2012, PloS one.
[16] M. Satake,et al. Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan , 2012, Journal of diabetes investigation.
[17] Jamal Ahmad,et al. Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus. , 2012, Archives of biochemistry and biophysics.
[18] J. Hayashi,et al. Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS) , 2011, Diabetologia.
[19] Elizabeth Selvin,et al. Performance of A1C for the Classification and Prediction of Diabetes , 2010, Diabetes Care.
[20] W. Jia,et al. Combined assessment of glycated albumin and fasting plasma glucose improves the detection of diabetes in Chinese subjects , 2010, Clinical and experimental pharmacology & physiology.
[21] L. Stevens,et al. Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] J. Pankow,et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.
[23] Yao-min Hu,et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance , 2010, Acta Diabetologica.
[24] J. Shaw,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[25] J. Mehta,et al. Effect of Statins on Fasting Plasma Glucose in Diabetic and Nondiabetic Patients , 2009, Journal of Investigative Medicine.
[26] Ciprian M Crainiceanu,et al. Short-term variability in measures of glycemia and implications for the classification of diabetes. , 2007, Archives of internal medicine.
[27] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[28] Anne Dawnay,et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. , 2003, The Biochemical journal.
[29] BOULIN,et al. [Classification and diagnosis of diabetes]. , 1953, Concours medical.